FINCH THERAPEUTICS GROUP INC (FNCH) Stock Balance Sheet
USA - NASDAQ:FNCH - US31773D2009 - Common Stock
1.8 USD
-0.18 (-9.09%)
1.8001 USD
+0 (+0.01%)
| MRQ (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 20.76M | 25.12M | 71.00M | 133.50M | 99.70M | |||
| Receivables | N/A | 0.00 | 100.00K | 500.00K | 1.10M | |||
| Other Current Assets | 413.00K | 723.00K | 3.40M | 8.60M | 5.40M | |||
| Total Current Assets | 21.18M | 25.85M | 74.60M | 142.60M | 106.20M | |||
| Non-Current Assets | ||||||||
| PPE Net | 26.57M | 27.18M | 48.70M | 24.70M | 7.00M | |||
| Goodwill | N/A | N/A | 0.00 | 18.10M | 18.10M | |||
| Intangibles | N/A | 0.00 | 32.90M | 32.90M | 32.90M | |||
| Other Non-Current Assets | 2.35M | 2.35M | 6.80M | 7.20M | 1.20M | |||
| Total Non-Current Assets | 28.92M | 29.53M | 88.30M | 82.80M | 59.10M | |||
| TOTAL ASSETS | 50.09M | 55.37M | 162.90M | 225.40M | 165.30M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 3.39M | 3.27M | 13.60M | 11.10M | 5.20M | |||
| Accounts Payable | 47.00K | 141.00K | 1.10M | 3.70M | 2.60M | |||
| Other Current Liabilities | 66.00K | 678.00K | N/A | 0.00 | 3.60M | |||
| Total Current Liabilities | 3.50M | 4.08M | 14.70M | 14.80M | 11.50M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 14.70M | 0.00 | 1.80M | |||
| Deferred Taxes/Income | N/A | 0.00 | 3.50M | 3.50M | 3.50M | |||
| Other Non-Current Liabilities | 27.55M | 28.40M | 34.40M | 4.90M | 11.20M | |||
| Total Non-Current Liabilities | 27.55M | 28.40M | 52.50M | 8.30M | 16.50M | |||
| TOTAL LIABILITIES | 31.05M | 32.49M | 67.20M | 23.10M | 28.00M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -354.27M | -350.39M | -275.60M | -161.00M | -102.80M | |||
| Additional Paid In Capital | 373.31M | 373.28M | 371.30M | 363.20M | 7.10M | |||
| Common Shares | 2.00K | 2.00K | 0.00 | 0.00 | 233.10M | |||
| Shares Outstanding | 1.61M | 1.61M | 1.60M | 1.60M | 1.60M | |||
| Tangible Book Value per Share | 11.86 | 14.25 | 39.25 | 94.50 | -91.75 | |||
| Total Shareholders' Equity | 19.04M | 22.89M | 95.70M | 202.20M | 137.30M | |||
| TOTAL LIABILITIES AND EQUITY | 50.09M | 55.37M | 162.90M | 225.40M | 165.30M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | 0.15 | N/A | 0.01 | |||
| Current Ratio | 6.05 | 6.33 | 5.07 | 9.64 | 9.23 | |||
| Return On Assets (ROA) | -32.51% | -135.00% | -70.38% | -25.80% | -23.80% | |||
| Return On Equity (ROE) | -85.55% | -326.64% | -119.80% | -28.76% | -28.65% | |||
All data in USD , ROIC based on taxRate of 0.21